Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.

Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.

Item

http://www.wikidata.org/entity/Q48359540

Q48359540

about

Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.

Item

http://www.wikidata.org/entity/Q48359540

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Retrospective analysis of lira ...... arget 1 year after initiation.

@en

Retrospective analysis of lira ...... arget 1 year after initiation.

@nl

type

Item

label

Retrospective analysis of lira ...... arget 1 year after initiation.

@en

Retrospective analysis of lira ...... arget 1 year after initiation.

@nl

prefLabel

Retrospective analysis of lira ...... arget 1 year after initiation.

@en

Retrospective analysis of lira ...... arget 1 year after initiation.

@nl

P1476

Retrospective analysis of lira ...... target 1 year after initiation

@en

P2093

Hitoshi Kuwata

http://www.w3.org/2001/XMLSchema#string

Kenta Murotani

http://www.w3.org/2001/XMLSchema#string

Yui Sakuramachi

http://www.w3.org/2001/XMLSchema#string

Yusuke Seino

http://www.w3.org/2001/XMLSchema#string

Yutaka Seino

http://www.w3.org/2001/XMLSchema#string

P2860

Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes

International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values

Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin-secreting capacity.

Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes

Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetes.

Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function.

Secretory units of islets in transplantation index is a useful predictor of insulin requirement in Japanese type 2 diabetic patients.

Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia).

One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial

Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36-week, randomized, double-blind, parallel-group trial.

P304

822-830

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JDI.12773

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29106046

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

6031501

http://www.w3.org/2001/XMLSchema#string

Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.

about

Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932